Category | Level | Subjects | Events | Incidence per 1000 years | Univariable | Multivariable (N=42 473) | ||||
HR | 95% CI | p Value | HR | 95% CI | p Value | |||||
All | 42 558 | 588 | 4.1 (3.8–4.5) | – | – | – | – | – | – | |
Sex | Female | 19 387 | 274 | 4.2 (3.8–4.7) | Ref | 0.64 | Ref | 0.57 | ||
Male | 23 102 | 314 | 4.1 (3.6–4.5) | 0.96 | 0.82 to 1.13 | 0.95 | 0.81 to 1.12 | |||
Age group | 0–14 | 2700 | 15 | 1.6 (1.0–2.7) | 0.33 | 0.2 to 0.56 | <0.001 | 0.37 | 0.22 to 0.62 | <0.001 |
15–44 | 24 493 | 377 | 4.8 (4.4–5.4) | Ref | Ref | |||||
45–64 | 8606 | 125 | 4.2 (3.5–5.0) | 0.89 | 0.72 to 1.09 | 0.94 | 0.76 to 1.16 | |||
65+ | 6742 | 71 | 2.8 (2.2–3.5) | 0.60 | 0.47 to 0.78 | 0.66 | 0.50 to 0.86 | |||
Region | London | 18 260 | 270 | 4.5 (4.0–5.1) | Ref | 0.07 | Ref | 0.07 | ||
Not London | 24 298 | 318 | 3.8 (3.4–4.3) | 0.86 | 0.73 to 1.01 | 0.85 | 0.71 to 1.01 | |||
Country of birth | UK born | 12 801 | 175 | 3.7 (3.2–4.3) | Ref | 0.49 | – | – | – | |
Non-UK born | 25 042 | 343 | 4.3 (3.9–4.8) | 0.90 | 0.75 to 1.08 | – | – | – | ||
Unknown | 4715 | 70 | 4.3 (3.4–5.4) | 1.00 | 0.77 to 1.30 | – | – | – | ||
Ethnic group | White | 11 255 | 133 | 3.1 (2.6–3.7) | Ref | 0.02 | Ref | <0.001 | ||
Black Caribbean | 1111 | 16 | 4.2 (2.6–6.9) | 1.29 | 0.77 to 2.17 | 1.17 | 0.69 to 1.99 | |||
Black African | 8024 | 95 | 4.1 (3.4–5.0) | 1.20 | 0.93 to 1.57 | 0.99 | 0.73 to 1.34 | |||
South Asian | 15 720 | 255 | 4.8 (4.2–5.4) | 1.48 | 1.12 to 1.82 | 1.54 | 1.23 to 1.93 | |||
Chinese | 611 | 10 | 4.9 (2.6–9.2) | 1.52 | 0.80 to 2.90 | 1.44 | 0.75 to 2.75 | |||
Other | 3789 | 44 | 3.9 (2.9–5.3) | 1.16 | 0.82 to 1.63 | 1.07 | 0.77 to 1.54 | |||
Unknown | 2048 | 35 | 5.0 (3.6–7.0) | 1.51 | 1.04 to 2.19 | 1.60 | 1.09 to 2.34 | |||
Site of disease | Pulmonary | 21 539 | 348 | 4.8 (4.3–5.3) | 1.24 | 1.00 to 1.55 | <0.001 | Ref | <0.001 | |
Pulmonary+ extrapulmonary | 2645 | 50 | 5.5 (4.2–7.3) | 1.45 | 1.04 to 2.04 | 1.07 | 0.79 to 1.44 | |||
Pleural | 2107 | 15 | 2.2 (1.3–3.7) | 0.57 | 0.33 to 0.98 | 0.42 | 0.25 to 0.72 | |||
Lymph node | 8208 | 104 | 3.9 (3.2–4.7) | Ref | 0.72 | 0.57 to 0.91 | ||||
Bone | 1505 | 9 | 1.8 (0.9–3.4) | 0.46 | 0.23 to 0.90 | 0.34 | 0.17 to 0.65 | |||
CNS | 807 | 8 | 3.0 (1.5–6.0) | 0.78 | 0.38 to 1.60 | 0.59 | 0.29 to 1.19 | |||
Miliary | 929 | 14 | 4.7 (2.8–7.9) | 1.2 | 0.69 to 2.10 | 0.86 | 0.50 to 1.48 | |||
>2 extrapulmonary sites | 1072 | 10 | 2.8 (1.5–5.3) | 0.74 | 0.38 to 1.40 | 0.51 | 0.27 to 0.96 | |||
Other extrapulmonary | 3746 | 30 | 2.5 (1.7–3.5) | 0.64 | 0.42 to 0.96 | 0.48 | 0.33 to 0.70 | |||
Culture | Not positive | 17 694 | 208 | 3.4 (3.0–3.9) | Ref | <0.001 | 0.87 | 0.72 to 1.03 | 0.11 | |
Positive | 24 864 | 380 | 4.6 (4.2–5.1) | 1.34 | 1.12 to 1.58 | Ref | ||||
Isoniazid* | Sensitive | 21 502 | 338 | 4.8 (4.3–5.3) | Ref | 0.52 | - | – | – | |
Resistant | 1328 | 17 | 4.2 (2.6–6.7) | 0.85 | 0.52 to 1.39 | - | – | – | ||
HIV | Not known +ve | 40 637 | 554 | 4.0 (3.7–4.3) | Ref | <0.01 | Ref | 0.01 | ||
Positive | 1921 | 34 | 7.6 (5.4–10.7) | 1.65 | 1.17 to 2.34 | 1.64 | 1.13 to 2.38 |
↵* Isolates with known susceptibility results.
Event=re-notification, South Asian, Indian, Pakistani and Bangladeshi ethnic groups.